A shortcut to mitochondrial signaling and pathology: A commentary on "Nonenzymatic formation of succinate in mitochondria under oxidative stress"

Free Radical Biology and Medicine

Volumn 41, Issue 1, 2006, Pages 41-45

  Brookes, Paul S ^a   Freeman, Robert S ^a   Barone, Maria Cecilia ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROPROPIONIC ACID; AMOBARBITAL; DIAZOXIDE; OXIDIZING AGENT; SUCCINIC ACID;

ARTICLE; CANCER; CANCER GROWTH; ISCHEMIC PRECONDITIONING; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 33745007332     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.03.019     Document Type: Note

References (51)

1. Kaelin Jr. W.G. The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing. Biochem. Biophys. Res. Commun. 338 (2005) 627-638
2. Ardehali H., Chen Z., Ko Y., Mejia-Alvarez R., and Marban E. Multiprotein complex containing succinate dehydrogenase confers mitochondrial ATP-sensitive K+ channel activity. Proc. Natl. Acad. Sci. USA 101 (2004) 11880-11885
3. He W., Miao F.J., Lin D.C., Schwandner R.T., Wang Z., Gao J., Chen J.L., Tian H., and Ling L. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 429 (2004) 188-193
4. Benevolenskaya E.V., Murray H.L., Branton P., Young R.A., and Kaelin Jr. W.G. Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Mol. Cell 18 (2005) 623-635
5. Brookes P.S., Levonen A.L., Shiva S., Sarti P., and Darley-Usmar V.M. Mitochondria: regulators of signal transduction by reactive oxygen and nitrogen species. Free Radic. Biol. Med. 33 (2002) 755-764
6. Fedotcheva N.I., Sokolov A.P., and Kondrashova M.N. Nonezymatic formation of succinate in mitochondria under oxidative stress. Free Radic. Biol. Med. (2006)
7. Krebs H.A., and Johnson W.A. The role of citric acid in intermediate metabolism in mammals. Enzymologia 4 (1937) 148-156
8. Desagher S., Glowinski J., and Premont J. Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J. Neurosci. 17 (1997) 9060-9067
9. Vlessis A.A., Bartos D., and Trunkey D. Importance of spontaneous alpha-ketoacid decarboxylation in experiments involving peroxide. Biochem. Biophys. Res. Commun. 170 (1990) 1281-1287
10. Bell E.L., Emerling B.M., and Chandel N.S. Mitochondrial regulation of oxygen sensing. Mitochondrion 5 (2005) 322-332
11. Haddad J.J. Oxygen sensing and oxidant/redox-related pathways. Biochem. Biophys. Res. Commun. 316 (2004) 969-977
12. Waypa G.B., and Schumacker P.T. Hypoxic pulmonary vasoconstriction: redox events in oxygen sensing. J. Appl. Physiol. 98 (2005) 404-414
13. Acker H. The oxygen sensing signal cascade under the influence of reactive oxygen species. Philos. Trans. R. Soc. Lond B: Biol. Sci. 360 (2005) 2201-2210
14. Weir E.K., Lopez-Barneo J., Buckler K.J., and Archer S.L. Acute oxygen-sensing mechanisms. N. Engl. J. Med. 353 (2005) 2042-2055
15. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., Tian Y.M., Masson N., Hamilton D.L., Jaakkola P., Barstead R., Hodgkin J., Maxwell P.H., Pugh C.W., Schofield C.J., and Ratcliffe P.J. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107 (2001) 43-54
16. Bruick R.K., and McKnight S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294 (2001) 1337-1340
17. Ivan M., Kondo K., Yang H., Kim W., Valiando J., Ohh M., Salic A., Asara J.M., Lane W.S., and Kaelin Jr. W.G. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292 (2001) 464-468
18. Jaakkola P., Mole D.R., Tian Y.M., Wilson M.I., Gielbert J., Gaskell S.J., Kriegsheim A., Hebestreit H.F., Mukherji M., Schofield C.J., Maxwell P.H., Pugh C.W., and Ratcliffe P.J. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292 (2001) 468-472
19. Kaelin W.G. Proline hydroxylation and gene expression. Annu. Rev. Biochem. 74 (2005) 115-128
20. Hewitson K.S., Granatino N., Welford R.W., McDonough M.A., and Schofield C.J. Oxidation by 2-oxoglutarate oxygenases: non-haem iron systems in catalysis and signalling. Philos. Transact. A: Math. Phys. Eng. Sci. 363 (2005) 807-828
21. Guzy R.D., Hoyos B., Robin E., Chen H., Liu L., Mansfield K.D., Simon M.C., Hammerling U., and Schumacker P.T. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 1 (2005) 401-408
22. Brunelle J.K., Bell E.L., Quesada N.M., Vercauteren K., Tiranti V., Zeviani M., Scarpulla R.C., and Chandel N.S. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab. 1 (2005) 409-414
23. Mansfield K.D., Guzy R.D., Pan Y., Young R.M., Cash T.P., Schumacker P.T., and Simon M.C. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation. Cell Metab. 1 (2005) 393-399
24. Tuderman L., Myllyla R., and Kivirikko K.I. Mechanism of the prolyl hydroxylase reaction. 1. Role of co-substrates. Eur. J. Biochem. 80 (1977) 341-348
25. Myllyla R., Tuderman L., and Kivirikko K.I. Mechanism of the prolyl hydroxylase reaction. 2. Kinetic analysis of the reaction sequence. Eur. J. Biochem. 80 (1977) 349-357
26. Gottlieb E., and Tomlinson I.P. Mitochondrial tumour suppressors: a genetic and biochemical update. Nat. Rev. Cancer 5 (2005) 857-866
27. Selak M.A., Armour S.M., MacKenzie E.D., Boulahbel H., Watson D.G., Mansfield K.D., Pan Y., Simon M.C., Thompson C.B., and Gottlieb E. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7 (2005) 77-85
28. Lee S., Nakamura E., Yang H., Wei W., Linggi M.S., Sajan M.P., Farese R.V., Freeman R.S., Carter B.D., Kaelin Jr. W.G., and Schlisio S. Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell 8 (2005) 155-167
29. Pollard P.J., Briere J.J., Alam N.A., Barwell J., Barclay E., Wortham N.C., Hunt T., Mitchell M., Olpin S., Moat S.J., Hargreaves I.P., Heales S.J., Chung Y.L., Griffiths J.R., Dalgleish A., McGrath J.A., Gleeson M.J., Hodgson S.V., Poulsom R., Rustin P., and Tomlinson I.P. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum. Mol. Genet. 14 (2005) 2231-2239
30. Ranganathan A.C., Nelson K.K., Rodriguez A.M., Kim K.H., Tower G.B., Rutter J.L., Brinckerhoff C.E., Huang T.T., Epstein C.J., Jeffrey J.J., and Melendez J.A. Manganese superoxide dismutase signals matrix metalloproteinase expression via H2O2-dependent ERK1/2 activation. J. Biol. Chem. 276 (2001) 14264-14270
31. Connor K.M., Subbaram S., Regan K.J., Nelson K.K., Mazurkiewicz J.E., Bartholomew P.J., Aplin A.E., Tai Y.T., Guirre-Ghiso J., Flores S.C., and Melendez J.A. Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation. J. Biol. Chem. 280 (2005) 16916-16924
32. Kaelin Jr. W.G. ROS: really involved in oxygen sensing. Cell Metab. 1 (2005) 357-358
33. Sadek H.A., Humphries K.M., Szweda P.A., and Szweda L.I. Selective inactivation of redox-sensitive mitochondrial enzymes during cardiac reperfusion. Arch. Biochem. Biophys. 406 (2002) 222-228
34. Armstrong J.S., Whiteman M., Yang H., and Jones D.P. The redox regulation of intermediary metabolism by a superoxide-aconitase rheostat. Bioessays 26 (2004) 894-900
35. Humphries K.M., and Szweda L.I. Selective inactivation of alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase: reaction of lipoic acid with 4-hydroxy-2-nonenal. Biochemistry 37 (1998) 15835-15841
36. Lu H., Dalgard C.L., Mohyeldin A., McFate T., Tait A.S., and Verma A. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J. Biol. Chem. 280 (2005) 41928-41939
37. Kim J.W., Tchernyshyov I., Semenza G.L., and Dang C.V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3 (2006) 177-185
38. Papandreou I., Cairns R.A., Fontana L., Lim A.L., and Denko N.C. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 3 (2006) 187-197
39. Mandrik K.A., Vonsovich V.A., and Vinogradov V.V. Kinetics of the inhibition of succinate dehydrogenase in bull adrenal cortex by malonate and oxaloacetate. Ukr. Biokhim. Zh. 55 (1983) 503-506
40. Kearney E.B., Ackrell B.A., and Mayr M. Tightly bound oxalacetate and the activation of succinate dehydrogenase. Biochem. Biophys. Res. Commun. 49 (1972) 1115-1121
41. Ackrell B.A., Kearney E.B., and Edmondson D. Mechanism of the reductive activation of succinate dehydrogenase. J. Biol. Chem. 250 (1975) 7114-7119
42. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
43. Ardehali H., and O'Rourke B. Mitochondrial K(ATP) channels in cell survival and death. J. Mol. Cell. Cardiol. 39 (2005) 7-16
44. Otani H. Reactive oxygen species as mediators of signal transduction in ischemic preconditioning. Antioxid. Redox. Signal. 6 (2004) 449-469
45. Facundo H.T., and Carreira R.S. de Paula, J. G.; Santos, C. C.; Ferranti, R.; Laurindo, F. R.; Kowaltowski, A. J. Ischemic preconditioning requires increases in reactive oxygen release independent of mitochondrial K(+) channel activity. Free Radic. Biol. Med. 40 (2006) 469-479
46. Burwell L.S., Nadtochiy S.M., Tompkins A.J., Young S., and Brookes P.S. Direct evidence for S-nitrosation of mitochondrial complex I. Biochem. J. 394 (2006) 627-634
47. Chen Q., Hoppel C.L., and Lesnefsky E.J. Blockade of electron transport before cardiac ischemia with the reversible inhibitor amobarbital protects rat heart mitochondria. J. Pharmacol. Exp. Ther. 316 (2006) 200-207
48. Kaelin Jr. W.G. The concept of synthetic lethality in the context of anticancer therapy. Nat. Rev. Cancer 5 (2005) 689-698
49. Hebert S.C. Physiology: orphan detectors of metabolism. Nature 429 (2004) 143-145
50. Ballinger S.W. Mitochondrial dysfunction in cardiovascular disease. Free Radic. Biol. Med. 38 (2005) 1278-1295
51. Palmieri F. The mitochondrial transporter family (SLC25): physiological and pathological implications. Pflugers Arch. 447 (2004) 689-709